North America Dry Eye Syndrome Therapeutics Market Report

North America Dry Eye Syndrome (DES) Therapeutics Market Report, By Product Type (Cyclosporine, Oral Corticosteroid, Artificial Tears, Omega Supplements and Punctal Plugs), Disease Type and Country – Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : hc1889 | Publish Date : Upcoming | Industry : Healthcare | Geography : North America


Dry eye disease is characterized by instability of the tear film that can be due to insufficient amount of tear production or due to poor quality of tear film, which results in increased evaporation of the tears. Additionally, in 2017, based on the America Journal of Ophthalmology, more than 16 million U.S. adults were diagnosed with dry eye disease. Whereas, twice as many women had been diagnosed than men. Moreover, the rising presence of dry eye disease in developed economies and increasing prevalence are adding fuel to North America DES therapeutics market in future.

Dry eye disease is characterized by instability of the tear film that can be due to insufficient amount of tear production or due to poor quality of tear film, which results in increased evaporation of the tears. Additionally, in 2017, based on the America Journal of Ophthalmology, more than 16 million U.S. adults were diagnosed with dry eye disease. Whereas, twice as many women had been diagnosed than men. Moreover, the rising presence of dry eye disease in developed economies and increasing prevalence are adding fuel to North America DES therapeutics market in future.

North America Dry Eye Syndrome Therapeutics Market Outlook

Growing number of eye care centers, technological advancements in North America DES therapeutics, increasing per capita health care expenditure and increasing investment of key players in the market in this region are some the major factors driving the growth of the North America DES therapeutics market. On the other hand, factors such as alternative therapies and high cost of specialty dry eye products are hampering the growth of the market.


North America Dry Eye Syndrome Therapeutics Segmental Overview

The North America DES therapeutics market is segmented by product type, disease type and Country.

North America Dry Eye Syndrome Therapeutics Market by Product Type

The products discussed in this report are cyclosporine, oral corticosteroid, artificial tears, omega supplements, punctal plugs and others. Furthermore, punctual plugs segment is classified into removable and dissolvable. Likewise, others segment include lid wipes, eye mask and specialized eye wares. Among various product types, the cyclosporine dominated the North America DES therapeutics market in 2018 and is also projected to lead the market by 2025. There are few alternatives which are as effective as cyclosporine which is helping the drug to hold strong dominance in the market.

North America Dry Eye Syndrome Therapeutics Market by Disease Type

The various disease types of the North America DES therapeutics market are covered in the report such as evaporative dry eye syndrome and aqueous dry eye syndrome. The aqueous dry eye syndrome segment dominated the market in 2018. This syndrome is caused by the tear gland damage, increase in the age and when the lacrimal gland fails to produce enough tears to coat the surface of the eye. Whereas, the market for evaporative dry eye syndrome is also projected to increase rapidly.

North America Dry Eye Syndrome Therapeutics Market by Country

By country, the North American North America dry eye syndrome therapeutics market is studied across the countries such as the U.S., Canada and Mexico. Dry eye syndrome is the most prevalent eye disease in the United States. This can be attributed to large patient pool in this region. Moreover, lifestyle disorders, increasing healthcare expenditure boost the growth of the market.

North America Dry Eye Syndrome Therapeutics Market Key Players

The key players profiled in the global North America DES therapeutics market are Allergan Plc, Akorn, Inc, Bausch Health Companies Inc, Similasan Corporation, I-Med Pharma Inc, Johnson and Johnson Vision care, Inc. (Johnson & Johnson), Medicom Healthcare, Alcon Laboratories, Inc. (Novartis AG), OASIS Medical, Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings), Reckitt Benckiser Group PLC, Santen Pharmaceutical Co Ltd, Sentiss Pharma Private limited, Shire Plc, Bayer AG, Sun Pharmaceutical Industries Limited, among others. New product launches, research and development and mergers & acquisitions are the key strategies adopted by market players to ensure their growth in the market.

The North America DES therapeutics market is segmented by product type, disease type and country. The products discussed in this report are cyclosporine, oral corticosteroid, artificial tears, omega supplements, punctal plugs and others. Furthermore, punctual plugs segment is classified into removable and dissolvable. Likewise, others segment include lid wipes, eye mask and specialized eye wares. Among various product types, the cyclosporine dominated the North America DES therapeutics market in 2018 and is also projected to lead the market by 2025. There are few alternatives which are as effective as cyclosporine which is helping the drug to hold strong dominance in the market.

The various disease types of the North America DES therapeutics market are covered in the report such as evaporative dry eye syndrome and aqueous dry eye syndrome. The aqueous dry eye syndrome segment dominated the market in 2018. This syndrome is caused by the tear gland damage, increase in the age and when the lacrimal gland fails to produce enough tears to coat the surface of the eye. Whereas, the market for evaporative dry eye syndrome is also projected to increase rapidly.

By country, the North American dermatology devices market is studied across the countries of North America. The report includes market size estimation & forecast for the regions such as the U.S., Canada and Mexico. Dry eye syndrome is the most prevalent eye disease in the United States. This can be attributed to large patient pool in this region. Moreover, lifestyle disorders, increasing healthcare expenditure boost the growth of the market.


Why to buy this report:

  • The report offers changing market dynamics in the North America DES therapeutics market, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of North America DES therapeutics, such as artificial tears market, aqueous dry eye syndrome market,
  • It presents a comprehensive assessment of regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the North America DES therapeutics market performance
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of North America DES therapeutics market